Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories
British drugmaker AstraZeneca has received more than $1 billion in U.S. funding to accelerate the development of Oxford University’s coronavirus vaccine candidate.